Clinical Trial Update: A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating carboplatin and paclitaxel with or without veliparib in HER2-negative metastatic or locally advanced unresectable BRCA-assoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brca-associated Breast Cancer
• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Veliparib (veliparib)

Snippet

Sponsor: AbbVie | Conditions: Metastatic Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2022-04-04